In antineutrophil cytoplasmic antibody-associated vasculitis (AAV), relapses constitute a challenge despite initial good control. Our objective was to investigate whether patients with relapses shared the same initial organ involvement.One hundred sixty patients with AAV in our center were investigated. Of these 160, 38 experienced relapse during followup. Clinical and laboratory data were analyzed.Among the 38 patients, there was a total of 55 relapse events, 39 (70.9%) of which had the same initial organ as in the initial onset.Relapses in AAV were likely to begin with the same organ as in the initial onset; this facilitates early recognition of relapses.SCI(E)PubMed0ARTICLE3448-503
Objectives: To determine predictors of renal relapse and end-stage renal failure (ESRF) in patients ...
Antineutrophil cytoplasmic antibodies (ANCA) are important serologic markers for ANCA-associated vas...
Objective. Nonsevere relapses are more common than severe relapses in antineutrophil cytoplasmic ant...
Objective. In antineutrophil cytoplasmic antibody-associated vasculitis (AAV), relapses constitute a...
Objective To determine the association between characteristics at diagnosis and the time to first re...
Current treatment based on the use of cyclophosphamide and corticosteroids has changed anti-neutroph...
Current treatment based on the use of cyclophosphamide and corticosteroids has changed anti-neutroph...
Objectives Relapses affect 30-50% of patients with ANCA-associated vasculitis (AAV) over 5 years,...
Background: Relapse of disease is frequent in anti-neutrophil cytoplasm antibody (ANCA)-associated v...
Objective. Treatment resistance and relapse in antineutrophil cytoplasmic antibody (ANCA)-associated...
Objectives: Relapses affect 30-50% of patients with ANCA-associated vasculitis (AAV) over 5 years, n...
In ANCA-associated vasculitis (AAV), renal relapses are cause of concern as they are unpredictable a...
BACKGROUND: Relapse of disease is frequent in anti-neutrophil cytoplasm antibody (ANCA)-associated v...
Objective. Disease relapses are frequent in anti-neutrophil cytoplasmic antibody-associated vasculit...
Objective. The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) form a grou...
Objectives: To determine predictors of renal relapse and end-stage renal failure (ESRF) in patients ...
Antineutrophil cytoplasmic antibodies (ANCA) are important serologic markers for ANCA-associated vas...
Objective. Nonsevere relapses are more common than severe relapses in antineutrophil cytoplasmic ant...
Objective. In antineutrophil cytoplasmic antibody-associated vasculitis (AAV), relapses constitute a...
Objective To determine the association between characteristics at diagnosis and the time to first re...
Current treatment based on the use of cyclophosphamide and corticosteroids has changed anti-neutroph...
Current treatment based on the use of cyclophosphamide and corticosteroids has changed anti-neutroph...
Objectives Relapses affect 30-50% of patients with ANCA-associated vasculitis (AAV) over 5 years,...
Background: Relapse of disease is frequent in anti-neutrophil cytoplasm antibody (ANCA)-associated v...
Objective. Treatment resistance and relapse in antineutrophil cytoplasmic antibody (ANCA)-associated...
Objectives: Relapses affect 30-50% of patients with ANCA-associated vasculitis (AAV) over 5 years, n...
In ANCA-associated vasculitis (AAV), renal relapses are cause of concern as they are unpredictable a...
BACKGROUND: Relapse of disease is frequent in anti-neutrophil cytoplasm antibody (ANCA)-associated v...
Objective. Disease relapses are frequent in anti-neutrophil cytoplasmic antibody-associated vasculit...
Objective. The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) form a grou...
Objectives: To determine predictors of renal relapse and end-stage renal failure (ESRF) in patients ...
Antineutrophil cytoplasmic antibodies (ANCA) are important serologic markers for ANCA-associated vas...
Objective. Nonsevere relapses are more common than severe relapses in antineutrophil cytoplasmic ant...